Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest?
At first sight, guidelines for implantation of an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction seem unambiguous. There are clear cut-off values for ejection fraction, and functional class. However, determination of the ejection fraction itself is not unambiguous, and other risk factors for sudden death that may have a profound effect on risk are not used for decision-making. Furthermore, to obtain a clinically significant impact on survival, expected longevity is important as it can greatly compromise the benefit in elderly patients but underestimate the long-term potential of ICD therapy in younger patients. (Neth Heart J 2009;17:107-10.).
Bracke
F A L E
FA
Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
Dekker
L R C
LR
van der Voort
P H
PH
Meijer
A
A